ArticleEuropean radiology2021

An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas.

Jingtao Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.